Compound Evidence File
#EC-2026-0807
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg)
Filed under Injectable Oils. The bureau holds 68 laboratory returns for this compound from 28 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
28 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 7 | 10.0 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 9.6 | 9.6 | 9.6 | 6 May 2025 | 6 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 3 | 9.3 | 8.2 | 10.0 | 23 May 2026 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 9.2 | 8.4 | 10.0 | 23 May 2026 | 23 May 2026 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 9.2 | 9.2 | 9.2 | 9 Jun 2025 | 9 Jun 2025 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | X | 1 | 9.1 | 9.1 | 9.1 | 16 Mar 2025 | 16 Mar 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.9 | 7.7 | 9.9 | 25 May 2026 | 25 May 2026 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 8.7 | 8.7 | 8.7 | 16 Mar 2025 | 16 Mar 2025 |
| Pure RawzCASE #VI-2026-0767 | X | 2 | 8.6 | 7.4 | 9.7 | 20 Jun 2025 | 23 May 2026 |
| HK PeptidesCASE #VI-2026-0140 | X | 8 | 8.4 | 5.6 | 10.0 | 8 Jul 2025 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.1 | 7.0 | 9.4 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 8.0 | 7.9 | 8.0 | 24 May 2026 | 24 May 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 8.0 | 8.0 | 8.0 | 14 Jan 2025 | 14 Jan 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.8 | 7.8 | 7.8 | 2 Apr 2025 | 2 Apr 2025 |
| Planet PeptideCASE #VI-2026-0092 | X | 2 | 6.8 | 5.9 | 7.6 | 28 Mar 2025 | 17 May 2026 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 1 | 6.7 | 6.7 | 6.7 | 27 Feb 2025 | 27 Feb 2025 |
| Prime PeptidesCASE #VI-2026-0696 | X | 1 | 6.5 | 6.5 | 6.5 | 16 Mar 2025 | 16 Mar 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 6.3 | 6.3 | 6.3 | 20 Jun 2025 | 20 Jun 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 5.7 | 5.7 | 5.7 | 8 Jul 2025 | 8 Jul 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 5.5 | 5.5 | 5.5 | 17 Dec 2024 | 17 Dec 2024 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 4.6 | 4.6 | 4.6 | 2 Apr 2025 | 2 Apr 2025 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 4.4 | 4.4 | 4.4 | 25 Apr 2025 | 25 Apr 2025 |
| Amino AmigosCASE #VI-2026-0061 | X | 2 | 4.3 | 4.2 | 4.5 | 28 Mar 2025 | 21 May 2026 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 3.7 | 3.7 | 3.7 | 25 Apr 2025 | 25 Apr 2025 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 2.3 | 2.3 | 2.3 | 9 Jun 2025 | 9 Jun 2025 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.0 | 0.0 | 0.0 | 6 May 2025 | 6 May 2025 |
Open any subject to view the batch-level evidence for Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) alone.